Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,517 | 30 | 57.2% |
| Consulting Fee | $28,228 | 15 | 38.0% |
| Travel and Lodging | $1,909 | 7 | 2.6% |
| Unspecified | $1,211 | 1 | 1.6% |
| Food and Beverage | $423.79 | 11 | 0.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim International GmbH | $28,345 | 33 | $0 (2023) |
| PFIZER INC. | $14,651 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $11,852 | 18 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,678 | 5 | $0 (2024) |
| Amgen Inc. | $4,836 | 2 | $0 (2018) |
| Boehringer Ingelheim Hong Kong Ltd. | $2,000 | 1 | $0 (2021) |
| Boehringer Ingelheim Do Brasil Quimica e Farmaceutical Ltda. | $1,875 | 1 | $0 (2020) |
| Boehringer Ingelheim Taiwan Ltd. | $1,594 | 1 | $0 (2021) |
| Horizon Therapeutics plc | $1,458 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,659 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,659) |
| 2023 | $8,346 | 7 | Boehringer Ingelheim International GmbH ($6,462) |
| 2022 | $1,350 | 3 | Boehringer Ingelheim International GmbH ($891.78) |
| 2021 | $11,878 | 14 | Boehringer Ingelheim International GmbH ($7,149) |
| 2020 | $11,697 | 13 | Boehringer Ingelheim International GmbH ($9,822) |
| 2019 | $12,520 | 20 | Gilead Sciences, Inc. ($11,852) |
| 2018 | $8,188 | 5 | Amgen Inc. ($4,836) |
| 2017 | $14,651 | 1 | PFIZER INC. ($14,651) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $5,659.11 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2023 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $695.13 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $617.89 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $265.52 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2023 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,097.05 | General |
| Category: RESPIRATORY | ||||||
| 02/17/2023 | Horizon Therapeutics plc | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 02/05/2023 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $569.50 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2023 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,100.50 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2022 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $618.00 | General |
| Category: RESPIRATORY | ||||||
| 09/01/2022 | Horizon Therapeutics plc | — | Consulting Fee | Cash or cash equivalent | $458.33 | General |
| 08/16/2022 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $273.78 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2021 | Boehringer Ingelheim Hong Kong Ltd. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2021 | Boehringer Ingelheim Taiwan Ltd. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,593.75 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $618.00 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $794.43 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $341.38 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $271.75 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $635.00 | General |
| Category: RESPIRATORY | ||||||
| 05/20/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: RESPIRATORY | ||||||
| 04/01/2021 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $299.00 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Simulating Population Disability Outcomes for Alternative Treatment Pathways in Patients With Active Rheumatoid Arthritis | Amgen Inc. | $1,211 | 1 |
About Dr. Eric Matteson, M.D
Dr. Eric Matteson, M.D is a Rheumatology healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982677563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Matteson, M.D has received a total of $74,289 in payments from pharmaceutical and medical device companies, with $5,659 received in 2024. These payments were reported across 64 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,517).
Practice Information
- Specialty Rheumatology
- Location Rochester, MN
- Active Since 02/13/2006
- Last Updated 03/14/2018
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1982677563
Products in Payments
- OFEV (Drug) $41,492
- Enbrel (Biological) $4,836
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Rochester
Dr. Delfin Santos, M.d, M.D
Rheumatology — Payments: $558,792
Cornelia Weyand, M.d, M.D
Rheumatology — Payments: $75,777
Kenneth Warrington, Md, MD
Rheumatology — Payments: $54,106
Ignacio Sanz, Md, MD
Rheumatology — Payments: $41,647
John Davis, M.d, M.D
Rheumatology — Payments: $34,273
Ashima Makol, M.d, M.D
Rheumatology — Payments: $17,025